Journal of Clinical Lipidology

Article	Citations
Hypolipidemia is associated with the severity of COVID-19	254
The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction	107
Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group	73
Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials	71
Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association	70
NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient	58
Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospitals during COVID-19 pandemic in Italy	50
Viewing atherosclerosis through a crystal lens: How the evolving structure of cholesterol crystals in atherosclerotic plaque alters its stability	50
The association between triglycerides and incident cardiovascular disease: What is “optimal”?	43
Ketogenic diets, not for everyone	39
Saturated fats and cardiovascular health: Current evidence and controversies	38
Long-term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia: Five-year data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER)	38
A simplified diagnosis algorithm for dysbetalipoproteinemia	38
PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study	36
Lipid lowering with bempedoic acid added to a proprotein convertase subtilisin/kexin type 9 inhibitor therapy: A randomized, controlled trial	35
Pharmacokinetics and pharmacodynamics of inclisiran, a small interfering RNA therapy, in patients with hepatic impairment	33
Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association	25
Effects of bempedoic acid on CRP, IL-6, fibrinogen and lipoprotein(a) in patients with residual inflammatory risk: A secondary analysis of the CLEAR harmony trial	23
A mechanism-based operational definition and classification of hypercholesterolemia	23
Association between antecedent statin use and severe disease outcomes in COVID-19: A retrospective study with propensity score matching	22
HDL proteome remodeling associates with COVID-19 severity	22
Guidance for the diagnosis and treatment of hypolipidemia disorders	22
Prognostic impact of cascade screening for familial hypercholesterolemia on cardiovascular events	21
A catalog of the pathogenic mutations of LDL receptor gene in Japanese familial hypercholesterolemia	21
Prevention of atherosclerotic cardiovascular disease in South Asians in the US: A clinical perspective from the National Lipid Association	21

Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials	21
Combined hyperlipidemia is genetically similar to isolated hypertriglyceridemia	20
Associations of GlycA and high-sensitivity C-reactive protein with measures of lipolysis in adults with obesity	20
Low levels of cholesterol and the cholesterol type are not associated with depression: Results of a cross-sectional NHANES study	20
The first Japanese cases of familial hypercholesterolemia due to a known pathogenic APOB gene variant, c.10580 G>A: p.(Arg3527Gln)	19
Triglyceride-lowering and anti-inflammatory mechanisms of omega-3 polyunsaturated fatty acids for atherosclerotic cardiovascular risk reduction	19
Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association	19
Real-world utilization of bempedoic acid in an academic preventive cardiology practice	18
Prevention of endothelial dysfunction and thrombotic events in COVID-19 patients with familial hypercholesterolemia	18
PCSK9 inhibition in clinical practice: Treatment patterns and attainment of lipid goals in a large health maintenance organization	18
Association between statin use and cognitive function: A systematic review of randomized clinical trials and observational studies	18
Assessment of efficacy and safety of volanesorsen for treatment of metabolic complications in patients with familial partial lipodystrophy: Results of the BROADEN study	18
Lipoprotein(a) concentration, genetic variants, apo(a) isoform size, and cellular cholesterol efflux in patients with elevated Lp(a) and coronary heart disease submitted or not to lipoprotein apheresi	17
Quantile-specific heritability of high-density lipoproteins with implications for precision medicine	17
Lipoprotein(a) levels and association with myocardial infarction and stroke in a nationally representative cross-sectional US cohort	17
High prevalence of plasma lipid abnormalities in human and canine Duchenne and Becker muscular dystrophies depicts a new type of primary genetic dyslipidemia	17
Small interfering ribonucleic acid for cholesterol lowering – Inclisiran	16
Association of high maternal triglyceride levels early and late in pregnancy with adverse outcomes: A retrospective cohort study	16
Effect of olezarsen targeting APOC-III on lipoprotein size and particle number measured by NMR in patients with hypertriglyceridemia	16
Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19	15
Cost-effectiveness of population-wide genomic screening for familial hypercholesterolemia in the United States	14
Lipoprotein(a) and inflammation- pathophysiological links and clinical implications for cardiovascular disease	14
Negative impact of COVID-19 pandemic on the lifestyle and management of patients with homozygous familial hypercholesterolemia	14
Effect of bariatric surgery on plasma levels of oxidised phospholipids, biomarkers of oxidised LDL and lipoprotein(a)	14
APOC3 inhibition with volanesorsen reduces hepatic steatosis in patients with severe hypertriglyceridemia	14
Effect of pharmacist interventions on reducing low-density lipoprotein cholesterol (LDL-C) levels: A systematic review and meta-analysis	13
Association of apolipoprotein C3 with insulin resistance and coronary artery calcium in patients with type 1 diabetes	13
Gene–environment interaction between APOA5 c.553G>T and pregnancy in hypertriglyceridemia-induced acute pancreatitis	13
Closing the gap: Identification and management of familial hypercholesterolemia in an integrated healthcare delivery system	13
Bempedoic acid for high-risk patients with CVD as adjunct lipid-lowering therapy: A cost-effectiveness analysis	12
Prevalence of severe hypertriglyceridemia and pancreatitis in familial partial lipodystrophy type 2	12
Long-term outcomes after acute myocardial infarction in patients with familial hypercholesterolemia: The French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction program	12
Familial hypercholesterolemia in Mexico: Initial insights from the national registry	11
C3 and alternative pathway components are associated with an adverse lipoprotein subclass profile: The CODAM study	11
Statin use and fall-related hospitalizations among residents of long-term care facilities: A case-control study	11
Efficacy and safety of pelacarsen in lowering Lp(a) in healthy Japanese subjects	11
Nutrition interventions for adults with dyslipidemia: A Clinical Perspective from the National Lipid Association	11
Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial	11
Efficacy of PCSK9 inhibitors in the treatment of heterozygous familial hypercholesterolemia: A clinical practice experience	10
Evolocumab in patients with homozygous familial hypercholesterolemia in India	10
The economic impact of familial hypercholesterolemia on productivity	10
Partial lipodystrophy, severe dyslipidaemia and insulin resistant diabetes as early signs of Werner syndrome	10
Clinical, genetic profile and therapy evaluation of 55 children and 5 adults with sitosterolemia	10
Characterizing lipid profiles associated with asymptomatic intracranial arterial stenosis in rural-dwelling adults: A population-based study	10
Comprehensive (apo)lipoprotein profiling in patients with genetic hypertriglyceridemia using LC-MS and NMR spectroscopy	10
Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial	10
Inclisiran creates unique opportunities and challenges for patient access to therapy: early experience in a United States Lipid Clinic	10
Race/ethnic and sex differences in the initiation of non-statin lipid-lowering medication following myocardial infarction	9
Characteristics and trends of PCSK9 inhibitor prescription fills in the United States	9
Mustard oil and cardiovascular health: Why the controversy?	9

Sex differences in LDL-C response to PCSK9 inhibitors: A real world experience	9
Association between remnant lipoprotein cholesterol, high-sensitivity C-reactive protein, and risk of atherosclerotic cardiovascular disease events in the Multi-Ethnic Study of Atherosclerosis (MESA)	9
Lower triglyceride levels are associated with better endothelial function	9
Misinterpreting data in lipidology in the era of COVID-19	8
Functional profiling of LDLR variants: Important evidence for variant classification	8
Lipoprotein (a) is associated with poor long-term prognosis in patients aged 80 years and older with acute coronary syndrome	8
Nut consumption, risk of cardiovascular mortality, and potential mediating mechanisms: The Women's Health Study	8
Intima-media thickness in treated and untreated patients with and without familial hypercholesterolemia: A systematic review and meta-analysis	8
JCL roundtable: Lipids and inflammation in atherosclerosis	8
Interrogation of selected genes influencing serum LDL-Cholesterol levels in patients with well characterized NAFLD	8
Health-related quality of life in homozygous familial hypercholesterolemia: A systematic review and meta-analysis	8
Greater than expected reduction in low-density lipoprotein-cholesterol (LDL-C) with bempedoic acid in a patient with heterozygous familial hypercholesterolemia (HeFH)	8
Neuroprotective associations of apolipoproteins A-I and A-II with neurofilament levels in early multiple sclerosis	8
Hyperlipidemia and risk for preclampsia	8
Mental status and physical activity in patients with homozygous familial hypercholesterolemia: A subgroup analysis of a nationwide survey (A-HIT1 registry)	8
The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint Clinical Perspective from the National Lipid Association and the American Society for Pre	8
The triglyceride to HDL-cholesterol ratio and chronic graft failure in renal transplantation	8
Sex‐related differences in premature cardiovascular disease in familial hypercholesterolemia	8
CERT2 ceramide- and phospholipid-based risk score and major adverse cardiovascular events: A systematic review and meta-analysis	8
Evidence for intensive LDL-C lowering for acute coronary syndrome: Recommendations from the Lipid Association of India	8
The longitudinal triglyceride phenotype in heterozygotes with LPL pathogenic variants	7
Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia: Implications for clinical diagnosis	7
Elevated LDL-cholesterol levels among lean mass hyper-responders on low-carbohydrate ketogenic diets deserve urgent clinical attention and further research	7
Impact of small dense low-density lipoprotein cholesterol on cholesterol crystals in patients with acute coronary syndrome: An optical coherence tomography study	7
Free fatty acids, cardiovascular disease, and mortality in the Multi-Ethnic Study of Atherosclerosis	7
Update on the omega-3 fatty acid trial landscape: A narrative review with implications for primary prevention	7
Effectiveness of medical nutrition therapy in the management of adult dyslipidemia: A systematic review and meta-analysis	7
Reference values for the triglyceride to high-density lipoprotein ratio and its association with cardiometabolic diseases in a mixed adult population: The ELSA-Brasil study	7
Lipidomic changes of LDL after consumption of Camelina sativa oil, fatty fish and lean fish in subjects with impaired glucose metabolism—A randomized controlled trial	7
Cholestasis as a dominating symptom of patients with CYP27A1 mutations: An analysis of 17 Chinese infants	7
Benefits of icosapent ethyl for enhancing residual cardiovascular risk reduction: A review of key findings from REDUCE-IT	7
Awareness, diagnosis and treatment of heterozygous familial hypercholesterolemia (HeFH) – Results of a US national survey	7
Prevalence of genetically verified familial hypercholesterolemia among young (<45 years) Norwegian patients hospitalized with acute myocardial infarction	7
GPIHBP1 autoantibody is an independent risk factor for the recurrence of hypertriglyceridemia-induced acute pancreatitis	6
Utility of metabolic syndrome as a risk enhancing factor in decision of statin use	6
High lipoprotein(a) levels predict severity of coronary artery disease in patients hospitalized for acute myocardial infarction. Data from the French RICO survey	6
The impact of dyslipidemia on early markers of endothelial and renal dysfunction in children	6
Subjects with familial hypercholesterolemia have lower aortic valve area and higher levels of inflammatory biomarkers	6
Effects of a 6-month dietary-induced weight loss on erythrocyte membrane omega-3 fatty acids and hepatic status of subjects with nonalcoholic fatty liver disease: The Fatty Liver in Obesity study	6
Lipid profiles and hypertriglyceridemia among transgender and gender diverse adults on gender-affirming hormone therapy	6
Importance of the triglyceride level in identifying patients with a Type III Hyperlipoproteinemia phenotype using the ApoB algorithm	6
Extreme elevations of low-density lipoprotein cholesterol with very low carbohydrate, high fat diets	6
Vasomotor symptoms and lipids/lipoprotein subclass metrics in midlife women: Does level of endogenous estradiol matter? The SWAN HDL Ancillary Study	6
Chronic kidney disease and statin eligibility	6
Plasma fatty acid profiles: Relationships with sex, age, and state-reported heart disease mortality rates in the United States	6
Relative effect of hypertriglyceridemia on non-HDLC and apolipoprotein B as cardiovascular disease risk markers	6
Concerns regarding NMR lipoprotein analyses performed on the Nightingale heath platform – Focus on LDL subclasses	6
Ancestry-specific profiles of genetic determinants of severe hypertriglyceridemia	6
Are statins safe in patients with COVID-19?	6
Pharmacodynamic relationship between PCSK9, alirocumab, and LDL-C lowering in the ODYSSEY CHOICE I trial	6
Familial hypercholesterolemia related admission for acute coronary syndrome in the United States: Incidence, predictors, and outcomes	6
The clinical effects of inclisiran, a first-in-class LDL-C lowering siRNA therapy, on the LDL-C levels in Chinese patients with hypercholesterolemia	6
Statin utilization and low-density lipoprotein cholesterol in statin-treated patients with atherosclerotic cardiovascular disease: Trends from a community-based health care delivery system, 2002–2016	6
Prevalence, severity and management of hypertriglyceridemia-associated pancreatitis; A 7-year retrospective cohort study at Canadian quaternary care hospitals	6
Managing cardiometabolic risk factors across a woman's lifespan: A lipidologist's perspective	6
Applying an LDL-C threshold-based approach to identify individuals with familial hypercholesterolemia	6
Cognitive function with evolocumab in pediatric heterozygous familial hypercholesterolemia	6
Diabetes and kidney dysfunction markedly alter the content of sphingolipids carried by circulating lipoproteins	5
Corneal confocal microscopy identifies small nerve fibre damage in patients with hypertriglyceridemia	5
Lipoprotein subtypes after testosterone therapy in transmasculine adolescents	5
The changing pattern of statin use in people with dementia: A population-based study	5
Involvement of a homozygous exon 6 deletion of LMF1 gene in intermittent severe hypertriglyceridemia	5
Volanesorsen, an antisense oligonucleotide to apolipoprotein C-III, increases lipoprotein lipase activity and lowers triglycerides in partial lipodystrophy	5
Management of diabetic dyslipidemia in Indians: Expert consensus statement from the Lipid Association of India	5
Atorvastatin-associated rhabdomyolysis in a patient with a novel variant of the SLCO1B1 gene: A case report	5
Familial hypobetalipoproteinemia caused by homozygous loss-of-function mutations in PCSK9: A case report	5
Exploring rates of PCSK9 inhibitor persistence and reasons for treatment non-persistence in an integrated specialty pharmacy model	5
Atherosclerotic cardiovascular disease in hyperalphalipoproteinemia due to LIPG variants	5
Is hypertriglyceridemia a reliable indicator of cholesterol-depleted Apo B particles?	5
Preβ1-high-density lipoprotein metabolism is delayed in patients with chronic kidney disease not on hemodialysis	5
Circulating levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) are associated with monocyte subsets in patients with stable coronary artery disease	5
Impact of a virtual lipid clinic on lipid-lowering therapy, LDL cholesterol levels, and outcomes in patients with acute coronary syndrome	5
Measurement of apolipoprotein B levels helps in the identification of patients at risk for hypertriglyceridemic pancreatitis	5
Reduction of cardiovascular events with the use of lipid-lowering medication in patients with familial hypercholesterolemia or severe primary hypercholesterolemia: A systematic review	5
Adherence to lipid monitoring and its impact on treatment intensification of LDL-C lowering therapies at an urban academic medical center	5
Perimenopausal transdermal estradiol replacement reduces serum HDL cholesterol efflux capacity but improves cardiovascular risk factors	5
Lower levels of low-density lipoprotein cholesterol are associated with a lower prevalence of thin-cap fibroatheroma in statin-treated patients with coronary artery disease	4
Lipoprotein(a) levels in children with homozygous familial hypercholesterolaemia: A cross-sectional study	4
Identifying reference values for serum lipids in Chinese children and adolescents aged 6–17 years old: A national multicenter study	4
Cardiometabolic risk factors in siblings from a statewide screening program	4

The ZPR1 genotype predicts myocardial infarction in patients with familial hypercholesterolemia	4
Non-high-density lipoprotein cholesterol and mortality among peritoneal dialysis patients	4
Incorporation of genetic testing significantly increases the number of individuals diagnosed with familial hypercholesterolemia	4
Genetic variants in SUSD2 are associated with the risk of ischemic heart disease	4
The importance of cascade genetic screening for diagnosing autosomal dominant hypercholesterolemia: Results from twenty years of a national screening program in Norway	4
A case of hyperchylomicronemia associated with GPIHBP1 autoantibodies and fluctuating thyroid autoimmune disease	4
Monocyte phenotyping and management of lipoprotein X syndrome	4
A cautionary tale: Is this APOB whole-gene duplication actually pathogenic?	4
Coronary computed tomography angiography evaluation of plaque morphology and its relationship to HDL and total cholesterol to HDL ratio	4
Attainment of low-density lipoprotein cholesterol goals in patients treated with combination therapy: A retrospective cohort study in primary care	4
Lipoprotein(a) and coronary artery calcium in comparison with other lipid biomarkers: The multi-ethnic study of atherosclerosis	4
Remnant cholesterol and risk of myocardial infarction in patients with coronary artery disease undergoing revascularization	4
Nutrition interventions for youth with dyslipidemia: a National Lipid Association clinical perspective	4
Why continued lipoprotein apheresis is vital for homozygous familial hypercholesterolemia patients with COVID-19	4
Lipoprotein(a), metabolic profile and new-onset type 2 diabetes in patients with familial combined hyperlipidemia: A 9 year follow-up study	4
BIO89-100, a GlycoPEGylated FGF21 Analog, Improved Serum Lipids and Extended Half-Life in a Controlled Single Ascending Dose Trial in Healthy Subjects†	4
Challenges in familial chylomicronemia syndrome diagnosis and management across Latin American countries: An expert panel discussion	4
Metabolic syndrome predicts cardiovascular risk and mortality in familial hypercholesterolemia	4
Time-averaged low-density lipoprotein cholesterol lowering with evolocumab: Pooled analysis of phase 2 trials	4
Prevalence and significance of risk enhancing biomarkers in the United States population at intermediate risk for atherosclerotic disease	4
Homozygous familial hypercholesterolemia in China: Genetic and clinical characteristics from a real-world, multi-center, cohort study	4
Diet-derived and diet-related endogenously produced palmitic acid: Effects on metabolic regulation and cardiovascular disease risk	4
Circulating GPIHBP1 levels and microvascular complications in patients with type 2 diabetes: A cross-sectional study	4
Association of patient, provider and facility related characteristics with statin associated side effects and statin use: Insight from the Veteran's Affairs healthcare system	4
Recommended and observed statin use among U.S. adults – National Health and Nutrition Examination Survey, 2011-2018	4
Impact of small dense low-density lipoprotein cholesterol and triglyceride-rich lipoproteins on plaque rupture with ST-segment elevation myocardial infarction	3
A retrospective cohort study evaluating the relationship between statin medication adherence and economic outcomes in commercial health plans	3
†Safety and Efficacy of Bempedoic Acid in Patients with Renal Impairment	3
Lipid levels, apolipoproteins, and risk of incident atrial fibrillation in men: A report from the Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD)	3
A variant in the fibronectin (FN1) gene, rs1250229-T, is associated with decreased risk of coronary artery disease in familial hypercholesterolaemia	3
Reduced Expression of Angiopoietin-Like Protein 3 via RNA Interference with ARO-ANG3 Produces Prolonged Reductions in LDL-C and Triglycerides in Dyslipidemic Patients	3
Recurrence for patients with first episode of hypertriglyceridemia-induced acute pancreatitis: A prospective cohort study	3
Circulating high density lipoprotein distinguishes alcoholic hepatitis from heavy drinkers and predicts 90-day outcome	3
JCL Roundtable: Global Think Tank on Lipoprotein(a)	3
Statins, lipids and dementia?	3
Quantifying the contribution of lipoprotein(a) to all apoB containing particles	3
Hypercholesterolemia exacerbated by a ketogenic diet	3
Forty year follow-up of three patients with complete absence of apolipoprotein B-containing lipoproteins	3
Severe hypertriglyceridemia secondary to splice-site and missense variants in LMF1 in three patients from Ecuador	3
Family history of diabetes determines the association of HOMA-IR with fasting and postprandial triglycerides in individuals with normal glucose tolerance	3
The Relationship of Alcohol Consumption and HDL Metabolism in the Multiethnic Dallas Heart Study	3
JCL roundtable: Healthy ethnic diets	3
Failure of cosegregation between a rare STAP1 missense variant and hypercholesterolemia	3
Association between lipoprotein(a) and long-term outcomes after percutaneous coronary intervention for lesions with in-stent restenosis	3
Evaluating the role of statins in prevention of preeclampsia: deeper insights into maternal cardiometabolic changes	3
Temporal decline in non–high-density lipoprotein cholesterol in subjects with diabetes mellitus without atherosclerotic cardiovascular disease	3
Prevention: The past, present, and future of medicine and society	3
Novel PPARG mutation in multiple family members with chylomicronemia	3
Monogenic and polygenic causes of low and extremely low LDL-C levels in patients referred to specialty lipid clinics: Genetics of low LDL-C	3
Longitudinal changes in HDL-cholesterol concentration are associated with different risk factors in primiparous and nulliparous young women: The NHLBI Growth and Health Study (NGHS)	3
Effect of evolocumab on fasting and post fat load lipids and lipoproteins in familial dysbetalipoproteinemia	3
Free fatty acids and heart failure in the Multi-Ethnic Study of Atherosclerosis (MESA)	3
LDL receptor and pathogen processes: Functions beyond normal lipids	3
Non-alcoholic fatty liver disease in patients with chylomicronemia syndromes	3
A retrospective analysis of clinical use of alirocumab in lipoprotein apheresis patients	3
A case of cerebrotendinous xanthomatosis with massive xanthomas but without a considerable increase in serum cholestanol levels	3
Comparison of two polygenic risk scores to identify non-monogenic primary hypocholesterolemias in a large cohort of Italian hypocholesterolemic subjects	3
The association between triglyceride-rich lipoproteins, circulating leukocytes, and low-grade inflammation: The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)	3
Fasting serum free glycerol concentration is a potential surrogate marker of visceral obesity and insulin sensitivity in middle-aged Japanese men	3